Home > Insider Trading > Filing (0001209191-22-017316)

Filing Details

Accession Number:: 0001209191-22-017316
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-08 19:32:07
Reporting Period:: 2022-03-04

Accepted Time:: 2022-03-08 19:32:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1582313	Xenon Pharmaceuticals Inc.	XENE	Pharmaceutical Preparations (2834)	980661854

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1665430	R. James Empfield	200 - 3650 Gilmore Way Burnaby A1 V5G 4W8	Evp, Drug Discovery	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2022-03-04	25,000	$8.40	35,000	No	4	M	Direct
Common Shares	Disposition	2022-03-04	6,685	$31.42	28,315	No	4	F	Direct
Common Shares	Disposition	2022-03-04	18,315	$30.79	10,000	No	4	S	Direct
Common Shares	Acquisiton	2022-03-07	2,500	$8.40	12,500	No	4	M	Direct
Common Shares	Disposition	2022-03-07	695	$30.23	11,805	No	4	F	Direct
Common Shares	Acquisiton	2022-03-07	40,000	$6.76	51,805	No	4	M	Direct
Common Shares	Disposition	2022-03-07	8,952	$30.23	42,853	No	4	F	Direct
Common Shares	Disposition	2022-03-07	1,805	$30.62	41,048	No	4	S	Direct
Common Shares	Disposition	2022-03-07	31,048	$30.54	10,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Stock Option (Right to Buy)	Disposition	2022-03-04	25,000	$0.00	25,000	$8.40
Common Shares	Stock Option (Right to Buy)	Disposition	2022-03-07	2,500	$0.00	2,500	$8.40
Common Shares	Stock Option (Right to Buy)	Disposition	2022-03-07	40,000	$0.00	40,000	$6.76

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2027-03-12	No	4	M	Direct
2027-03-12	No	4	M	Direct
2026-02-07	No	4	M	Direct

Footnotes

Represents the closing price of the Company's common shares on March 3, 2022 which was converted to a Canadian dollar amount for purposes of net settlement calculations.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.21 to $31.0296, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Represents the closing price of the Company's common shares on March 4, 2022 which was converted to a Canadian dollar amount for purposes of net settlement calculations.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.5161 to $30.6208, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Vesting 25% on February 9, 2017 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.